Tag: Fibrocell

Exton’s Fibrocell has been granted the Rare Pediatric Disease Designation by the Food and Drug Administration for its gene therapy candidate to treat children…

Fibrocell Science’s newest gene therapy treatment is now spreading its wings after helping treat the first patient suffering from fragile, easily blistered skin associated…

Exton’s Fibrocell Science has made some changes in its leadership by appointing John Maslowski as Chief Executive Officer and Douglas Swirsky as Chairman of…

Exton’s Fibrocell Science has let go of 24 employees and is actively looking for a buyer for azficel-T, its experimental treatment for vocal…

Exton based Fibrocell Science saw over a third of its share value disappear on Wednesday, after it announced disappointing results from the second-stage clinical…

VISTA Today Daily News Business Briefs are concise stories that bring you up to date with what’s going on around Chester County. This morning…

VISTA Today’s daily news briefs are concise, accurate stories that focus on Chester County companies.

New Brandywine Hospital CEO Appointed

The Brandywine Hospital Board…

Chester County business daily news briefs review yesterday’s business stories important to Chester County and beyond.

Chester County Library System’s (CCLS) Annual Report…

Don’t look now but shares of Fibrocell (FCSC: NYSE), the Exton-based company focused on developing treatments for rare and serious skin and connective…

Chester County cell therapy developer Fibrocell Science Inc. of Exton expects to file its first quarter financial report this week after a five-day delay…